| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10593102 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
The elaboration of a novel scaffold for the inhibition of JAK2 and FAK kinases was targeted in order to provide a dual inhibitor that could target divergent pathways for tumor cell progression.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Craig A. Zificsak, Diane E. Gingrich, Henry J. Breslin, Derek D. Dunn, Karen L. Milkiewicz, Jay P. Theroff, Tho V. Thieu, Ted L. Underiner, Linda R. Weinberg, Lisa D. Aimone, Mark S. Albom, Jennifer L. Mason, Lisa Saville, Jean Husten, Thelma S. Angeles,